Fagron NV FAGR-BE:Euronext Brussels

*Data is delayed | EUR
Last | 5:35 PM CET
19.41quote price arrow down-0.12 (-0.61%)
Volume
65,412
52 week range
13.85 - 22.16

...

Loading . . .

KEY STATS

  • Open19.49
  • Day High19.50
  • Day Low19.23
  • Prev Close19.53
  • 52 Week High22.16
  • 52 Week High Date10/12/20
  • 52 Week Low13.85
  • 52 Week Low Date03/19/20
  • Market Cap1,727.18M
  • Shares Out72.08M
  • 10 Day Average Volume120,660.2
  • Dividend0.08
  • Dividend Yield0.41%
  • Beta0.43
  • 1 Year % Change-2.07

RATIOS/PROFITABILITY

  • EPS (TTM)0.83
  • P/E (TTM)23.39
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/14/2020
  • Div Amount0.08
  • Split Date-
  • Split Factor-

Latest Fagron NV News

There is no recent news for this security.

Latest FAGR-BE News From Our Partners

QUOTE FINDER

Profile

MORE
Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and...
Koen Hoffman
Chairman
Rafael Padilla
Chief Executive Officer
Karin de Jong
Chief Financial Officer
Address
Venecoweg 20A
Nazareth
9810
Belgium